Guangzhou LBP Medicine Science & Technology Co Ltd (688393) - Total Liabilities
Based on the latest financial reports, Guangzhou LBP Medicine Science & Technology Co Ltd (688393) has total liabilities worth CN¥113.31 Million CNY (≈ $16.58 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Guangzhou LBP Medicine Science & Technol to evaluate the company's liquid asset resilience ratio.
Guangzhou LBP Medicine Science & Technology Co Ltd - Total Liabilities Trend (2011–2024)
This chart illustrates how Guangzhou LBP Medicine Science & Technology Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Guangzhou LBP Medicine Science & Technol assets under control.
Guangzhou LBP Medicine Science & Technology Co Ltd Competitors by Total Liabilities
The table below lists competitors of Guangzhou LBP Medicine Science & Technology Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Nalwa Sons Investments Limited
NSE:NSIL
|
India | Rs19.65 Billion |
|
Armata Pharmaceuticals Inc
NYSE MKT:ARMP
|
USA | $295.48 Million |
|
Sappe Public Company Limited
BK:SAPPE
|
Thailand | ฿1.10 Billion |
|
Eaton Vance Senior Floating Rate Closed Fund
NYSE:EFR
|
USA | $104.27 Million |
|
Sinomach General Machinery Science Technology Co Ltd
SHG:600444
|
China | CN¥760.72 Million |
|
Zhejiang Dilong New Material Co Ltd
SHE:002247
|
China | CN¥281.35 Million |
|
Echoiq Ltd
AU:EIQ
|
Australia | AU$718.61K |
|
Hengxin Mobile Business
SHE:300081
|
China | CN¥977.43 Million |
Liability Composition Analysis (2011–2024)
This chart breaks down Guangzhou LBP Medicine Science & Technology Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Guangzhou LBP Medicine Science & Technol balance sheet independence to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 9.05 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.09 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.09 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Guangzhou LBP Medicine Science & Technology Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Guangzhou LBP Medicine Science & Technology Co Ltd (2011–2024)
The table below shows the annual total liabilities of Guangzhou LBP Medicine Science & Technology Co Ltd from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥130.99 Million ≈ $19.17 Million |
-18.96% |
| 2023-12-31 | CN¥161.63 Million ≈ $23.65 Million |
-5.17% |
| 2022-12-31 | CN¥170.45 Million ≈ $24.94 Million |
+9.29% |
| 2021-12-31 | CN¥155.96 Million ≈ $22.82 Million |
+25.10% |
| 2020-12-31 | CN¥124.67 Million ≈ $18.24 Million |
+33.57% |
| 2019-12-31 | CN¥93.33 Million ≈ $13.66 Million |
+6.97% |
| 2018-12-31 | CN¥87.25 Million ≈ $12.77 Million |
+32.64% |
| 2017-12-31 | CN¥65.78 Million ≈ $9.63 Million |
+82.31% |
| 2016-12-31 | CN¥36.08 Million ≈ $5.28 Million |
-14.36% |
| 2013-12-31 | CN¥42.13 Million ≈ $6.17 Million |
+126.55% |
| 2012-12-31 | CN¥18.60 Million ≈ $2.72 Million |
-70.63% |
| 2011-12-31 | CN¥63.31 Million ≈ $9.26 Million |
-- |
About Guangzhou LBP Medicine Science & Technology Co Ltd
Guangzhou LBP Medicine Science & Technology Co., Ltd. engages in the research, development, and production of pathological diagnosis products in China and internationally. The company offers pathological diagnostic reagents and ancillary equipment that consists of liquid-based cytology products, including liquid-based cytology production machines and automatic sample transfer machines; polymerase… Read more